本报道最初发表于Endpoints News。请点击这里查看原文
The leader of the FDA’s drug division, Tracy Beth Høeg, is expected to depart the agency, as part of a broad shakeup at the top of the agency after the exit of now-former commissioner Marty Makary, according to an internal message reviewed by Endpoints News.
据Endpoints News审阅的一则内部消息称,美国食品药品监督管理局(FDA)药品评价和研究中心主任Tracy Beth Høeg预计将离开该机构,此举是该机构在现已离任的局长马蒂•马卡里(Marty Makary)离任后进行高层大幅调整的一部分。
您已阅读11%(417字),剩余89%(3475字)包含更多重要信息,订阅以继续探索完整内容,并享受更多专属服务。